4.0
May 18, 2022
Current employee, more than 5 years
Moscow, Moskva
Recommend
CEO approval
Business Outlook
Pros
Working on cutting edge research Various tasks The company makes serious innovations in pharmacology
Cons
Weak organization Salaries below average Poor communication between teams